Should pregnant mothers be immunized against smallpox? Poliomyelitis?
What is the incidence of fetal loss or major congenital anomalies if a pregnant woman contracts rubella? Poliomyelitis? Rubeola? Mumps? Or varicella? Is there a relationship to the time of the infection during pregnancy and congenital anomalies?
Is there a higher fetal mortality associated with the use of the sulfonylurea drugs for pregnant diabetic mothers?
Are progesteroids harmless to the fetus when given to a pregnant woman? Anti-thyroid drugs? Thiazides?
Get full access to this article
View all access options for this article.
References
1.
Gregg, N.M.: Congenital cataracts following German measles in the mother. Trans. Ophthal. Soc. Aust.3: 35, 1942.
2.
New South Wales, 1945: Occurrence of congenital defects in children following maternal rubella during pregnancy. Med. J. Aust.2: 122, 1945.
3.
Swan, C., A.L. Tostein, B. Moore, H. Mayo and G.H.B. Black: Congenital defects in infants following infectious disease during pregnancy . Med. J. Aust.2: 201, 1943.
4.
Swan, C., A.L. Tostein, B. Moore, H. Mayo and G.H.B. Black: Further observations on congenital defects in infants following infectious diseases during pregnancy with special reference to rubella. Med. J. Aust.1: 409, 1944.
5.
Lundström, R. : Rubella during pregnancy. Its effect upon perinatal mortality, the incidence of congenital abnormalities and immaturity. A preliminary report. Acta Paediat. (Uppsala)41: 583, 1952.
6.
Manson, M.M., W.P.D. Logan and R.M. Loy: Rubella and Other Virus Infections during Pregnancy: Reports on Public Health and Medical Subjects No. 101. H. M. S. Stationery Office , London, 1960.
7.
Aycock, W.L. and T.H. Ingals: Maternal disease as a principle in the epidemiology of congenital anomalies. Am. J. Med. Sci.212: 366, 1946.
8.
Katz, S.: Efficacy and hazards of vaccines. N. Eng. J. Med.17: 884, 1964.
9.
Page, L.: Case records of the Massachusetts General Hospital. N. Eng. J. Med. In Press.
10.
Naidoo, P. and H. Hirsch: Prenatal vaccinia. Lancet1: 196, 1963.
11.
Entwhistle, D.M., P.T. Bray and K.M. Lawrence: Prenatal infection with vaccinia virus . Brit. Med. J.2: 238, 1962.
12.
Taussig, H.B. : Thalidomide and phocomelia. Pediatrics30: 654, 1962.
13.
McBride, W.G. : Thalidomide and congenital anomalies. Lancet2: 1358, 1961.
14.
Speirs, A.L. : Thalidomide and congenital anomalies. Lancet1: 303, 1962.
15.
Lenz, W.: Klindlicke misslildungen noch medikament während der gravidität. Deutsch. Med. Wschr.86: 2555, 1961.
16.
Larrson, Y. and G. Sterky: Possible tetragenic effect of tolbutamide in a pregnant prediabetic. Lancet2: 1424, 1960.
17.
Tuchmann-Duplessis, H. and L. Mercier-Parat: Letter to editor, oral anti-diabetic drugs and tetratogenicity. Lancet1: 408, 1963.
18.
Jackson, W.P.U. , G.D. Campbell, M. Notelovitz and D. Blumsohn: Tolbutamide and chlorpropamide during pregnancy in human diabetes. Diabetes11 (Suppl.): 98, 1962.
19.
Gellis, S. and D. Hsia: The infant of the diabetic mother. J. Dis. Children1: 97, 1959.
20.
Cohlan, S.Q. , G. Bevelander and T. Tiamsic: Growth inhibitions of prematures receiving tetracycline. Am. J. Dis. Child.105: 453, 1963 .
21.
Carter, M.P. and F. Wilson: Tetracycline and congenital limb abnormalities . Brit. Med. J.2: 407, 1962.
22.
Editorial: Toxicity of tetracycline, Lancet2: 283, 1963.
23.
Nellhaus, G. : Artificially induced female pseudohermaphroditism . N. Eng. J. Med.258: 935, 1958.
24.
Jost, A.: Problems of fetal endocrinology: the gonadal and hypophyseal hormones . Recent Progress Hormone Research8: 379. 1953.
25.
Bretnall. L.P.: A case of arrhenoblastoma complicating pregnancy. J. Obst. and Gynaec. Brit. Empire52: 235, 1945.
26.
Feliciessio, PauloXavier and de Abreu Junqueria: Rev. Gynec. and Obst.1: 356, 1938, quoted by C.T. Jovert and W.F. Finn: Arrhenoblastoma, the incidence of malignancy and relationship to pregnancy, to sterility, and to treatment. Cancer4: 60, 1951.
27.
Block. J.A. and J.F.R. Bentley: Effect on the foetus of androgens given during pregnancy. Lancet1: 21, 1959.
28.
Wilkins, L. : Masculinization of the female fetus due to use of orally given progestins. J. A. M. A.172: 1028, 1960.
29.
Wilkins, L. , H.W. Jones, G.H. Holman and R.S. Stempfel, Jr.: Masculinization of the female fetus associated with the administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphroditism. J. Clin. Endocrinol.18: 559, 1958.
30.
Bongiovanni, A.M., A.M. DiGeorge and M.M. Grumbach: Masculinization of the female infant associated with estrogenic therapy alone during gestation (letter to editors) . J. Clin. Endocrinol.19: 1004, 1959.
31.
Migeon, C.J. : Somatic Stability of the Newly Born. Ciba Symposium, London, W. D. andJ. and A. Churchill Ltd. , 1961, p. 215.
32.
Migeon, C.J. : Hormonal Influences on the Neonate in Perinatal Pharmacology. Report of the Forty-first Ross Conference on Pediatric Research . C. D. May, ed., Columbus, Ohio, Ross Laboratories, 1962, p. 40.
33.
Frisk, A.R. and E. Josefsson: Thyrotoxicosis in a newborn, one month post partum. Acta Med. Scand., Suppl. 196: 85, 1947.
34.
Saxena, K.: Personal communication.
35.
Esmann, V., H.J. Jensen and K. Lundback: Disappearance of waxy exudates in diabetic retinopathy during administration of P-amino-saticylate. Acta Med. Scand.174: 99, 1963.
36.
Rodriguez, S.U., S.L. Leiken and M.D. Hiller: Neonatal thrombocytopenia associated with ante-partum administration of thiazide drugs. N. Eng. J. Med.270: 881, 1964.
37.
McKay, J. and G. Lucey: Medical progress: Neonatology. N. Eng. J. Med.270: 1231, 1964.
38.
Lucey, J.F. : Hazards to the newborn infant from drugs administered to the mother. Ped. Clin. N. A.8: 411, 1961.
